Results of solitary pancreas transplantation with enteric drainage: Is there a benefit from monitoring urinary amylase levels?

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1700-

  Odorico, J S ^a,b   Pirsch, J D ^a   Becker, Y T ^a   Knechtle, S J ^a   D'Alessandro, A ^a   Werwinski, C ^a   Sollinger, H W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CORTICOSTEROID; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MONITORING; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SURGICAL DRAINAGE; URINE LEVEL;

ACUTE DISEASE; AMYLASES; ANASTOMOSIS, SURGICAL; BIOLOGICAL MARKERS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTESTINES; KIDNEY TRANSPLANTATION; PANCREAS; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0035085906     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02648-8     Document Type: Conference Paper

References (1)

1. Gruessman AC, Sutherland DER: In: Cecka JM, Terasaki PI (eds) Clinical Transplants 1999. Los Angeles, Calif; UCLA Immunogenetics Center; 2000